CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice

Pharmacological Research

Volumn 61, Issue 1, 2010, Pages 27-33

  Guijarro, Ana ^a   Fu, Jin ^a   Astarita, Giuseppe ^a   Piomelli, Daniele ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

Author keywords

CD36; Feeding; Oleoylethanolamide; Small intestine

Indexed keywords

CD36 ANTIGEN; N OLEOYLETHANOLAMINE;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DUODENUM; FOOD INTAKE; GENE DELETION; HEART; JEJUNUM; KIDNEY PARENCHYMA; LIGHT DARK CYCLE; LIVER; MOUSE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; PROTEIN FUNCTION; SKELETAL MUSCLE; STOMACH; WHITE ADIPOSE TISSUE;

ANIMALS; ANTIGENS, CD36; BRAIN; CIRCADIAN RHYTHM; DOWN-REGULATION; FATTY ACIDS; FEEDING BEHAVIOR; GENE DELETION; JEJUNUM; KIDNEY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLEIC ACIDS;

EID: 72749094667     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2009.09.003     Document Type: Article

References (43)

1. Okamoto Y., Morishita J., Tsuboi K., Tonai T., and Ueda N. Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem 279 (2004) 5298-5305
2. Wang J., Okamoto Y., Morishita J., Tsuboi K., Miyatake A., and Ueda N. Functional analysis of the purified anandamide-generating phospholipase D as a member of the metallo-beta-lactamase family. J Biol Chem 281 (2006) 12325-12335
3. Ahn K., McKinney M.K., and Cravatt B.F. Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev 108 (2008) 1687-1707
4. Cravatt B.F., Giang D.K., Mayfield S.P., Boger D.L., Lerner R.A., and Gilula N.B. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384 (1996) 83-87
5. Tsuboi K., Takezaki N., and Ueda N. The N-acylethanolamine-hydrolyzing acid amidase (NAAA). Chem Biodivers 4 (2007) 1914-1925
6. Ueda N., Yamanaka K., and Yamamoto S. Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance. J Biol Chem 276 (2001) 35552-35557
7. Fu J., Astarita G., Gaetani S., Kim J., Cravatt B.F., Mackie K., et al. Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine. J Biol Chem 282 (2007) 1518-1528
8. Fu J., Kim J., Oveisi F., Astarita G., and Piomelli D. Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats. Am J Physiol Regul Integr Comp Physiol 295 (2008) R45-50
9. Rodriguez de Fonseca F., Navarro M., Gomez R., Escuredo L., Nava F., Fu J., et al. An anorexic lipid mediator regulated by feeding. Nature 414 (2001) 209-212
10. Schwartz G.J., Fu J., Astarita G., Li X., Gaetani S., Campolongo P., et al. The lipid messenger OEA links dietary fat intake to satiety. Cell Metab 8 (2008) 281-288
11. Fu J., Gaetani S., Oveisi F., Lo Verme J., Serrano A., Rodriguez De Fonseca F., et al. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature 425 (2003) 90-93
12. Bookout A.L., Jeong Y., Downes M., Yu R.T., Evans R.M., and Mangelsdorf D.J. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126 (2006) 789-799
13. Evans R.M., Barish G.D., and Wang Y.X. PPARs and the complex journey to obesity. Nat Med 10 (2004) 355-361
14. Lefebvre P., Chinetti G., Fruchart J.C., and Staels B. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 116 (2006) 571-580
15. Abumrad N.A., el-Maghrabi M.R., Amri E.Z., Lopez E., and Grimaldi P.A. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J Biol Chem 268 (1993) 17665-17668
16. Bonen A., Campbell S.E., Benton C.R., Chabowski A., Coort S.L., Han X.X., et al. Regulation of fatty acid transport by fatty acid translocase/CD36. Proc Nutr Soc 63 (2004) 245-249
17. Brinkmann J.F., Pelsers M.M., van Nieuwenhoven F.A., Tandon N.N., van der Vusse G.J., and Glatz J.F. Purification, immunochemical quantification and localization in rat heart of putative fatty acid translocase (FAT/CD36). Mol Cell Biochem 284 (2006) 127-134
18. Ehehalt R., Fullekrug J., Pohl J., Ring A., Herrmann T., and Stremmel W. Translocation of long chain fatty acids across the plasma membrane-lipid rafts and fatty acid transport proteins. Mol Cell Biochem 284 (2006) 135-140
19. Febbraio M., Abumrad N.A., Hajjar D.P., Sharma K., Cheng W., Pearce S.F., et al. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem 274 (1999) 19055-19062
20. Koonen D.P., Glatz J.F., Bonen A., and Luiken J.J. Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle. Biochim Biophys Acta 1736 (2005) 163-180
21. Nassir F., Wilson B., Han X., Gross R.W., and Abumrad N.A. CD36 is important for fatty acid and cholesterol uptake by the proximal but not distal intestine. J Biol Chem 282 (2007) 19493-19501
22. Poirier H., Degrace P., Niot I., Bernard A., and Besnard P. Localization and regulation of the putative membrane fatty-acid transporter (FAT) in the small intestine. Comparison with fatty acid-binding proteins (FABP). Eur J Biochem 238 (1996) 368-373
23. Van Nieuwenhoven F.A., Verstijnen C.P., Abumrad N.A., Willemsen P.H., Van Eys G.J., Van der Vusse G.J., et al. Putative membrane fatty acid translocase and cytoplasmic fatty acid-binding protein are co-expressed in rat heart and skeletal muscles. Biochem Biophys Res Commun 207 (1995) 747-752
24. Chen M., Yang Y., Braunstein E., Georgeson K.E., and Harmon C.M. Gut expression and regulation of FAT/CD36: possible role in fatty acid transport in rat enterocytes. Am J Physiol Endocrinol Metab 281 (2001) E916-E923
25. Coburn C.T., Hajri T., Ibrahimi A., and Abumrad N.A. Role of CD36 in membrane transport and utilization of long-chain fatty acids by different tissues. J Mol Neurosci 16 (2001) 117-121 [discussion 151-7]
26. Coburn C.T., Knapp Jr. F.F., Febbraio M., Beets A.L., Silverstein R.L., and Abumrad N.A. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 275 (2000) 32523-32529
27. Goudriaan J.R., Dahlmans V.E., Teusink B., Ouwens D.M., Febbraio M., Maassen J.A., et al. CD36 deficiency increases insulin sensitivity in muscle, but induces insulin resistance in the liver in mice. J Lipid Res 44 (2003) 2270-2277
28. Hajri T., Han X.X., Bonen A., and Abumrad N.A. Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice. J Clin Invest 109 (2002) 1381-1389
29. Hajri T., Ibrahimi A., Coburn C.T., Knapp Jr. F.F., Kurtz T., Pravenec M., et al. Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy. J Biol Chem 276 (2001) 23661-23666
30. Giuffrida A., Rodriguez de Fonseca F., and Piomelli D. Quantification of bioactive acylethanolamides in rat plasma by electrospray mass spectrometry. Anal Biochem 280 (2000) 87-93
31. Goudriaan J.R., Dahlmans V.E., Febbraio M., Teusink B., Romijn J.A., Havekes L.M., et al. Intestinal lipid absorption is not affected in CD36 deficient mice. Mol Cell Biochem 239 (2002) 199-202
32. Drover V.A., Ajmal M., Nassir F., Davidson N.O., Nauli A.M., Sahoo D., et al. CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. J Clin Invest 115 (2005) 1290-1297
33. Gimeno R.E., Hirsch D.J., Punreddy S., Sun Y., Ortegon A.M., Wu H., et al. Targeted deletion of fatty acid transport protein-4 results in early embryonic lethality. J Biol Chem 278 (2003) 49512-49516
34. Stahl A., Hirsch D.J., Gimeno R.E., Punreddy S., Ge P., Watson N., et al. Identification of the major intestinal fatty acid transport protein. Mol Cell 4 (1999) 299-308
35. Borrelli Fand Izzo A.A. Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance. Best Pract Res Clin Endocrinol Metab 23 (2009) 33-49
36. Hansen H.S., and Diep T.A. N-acylethanolamines, anandamide and food intake. Biochem Pharmacol 78 (2009) 553-560
37. Pravenec M., Churchill P.C., Churchill M.C., Viklicky O., Kazdova L., Aitman T.J., et al. Identification of renal Cd36 as a determinant of blood pressure and risk for hypertension. Nat Genet 40 (2008) 952-954
38. Hirano K., Kuwasako T., Nakagawa-Toyama Y., Janabi M., Yamashita S., and Matsuzawa Y. Pathophysiology of human genetic CD36 deficiency. Trends Cardiovasc Med 13 (2003) 136-141
39. Koonen D.P., Febbraio M., Bonnet S., Nagendran J., Young M.E., Michelakis E.D., et al. CD36 expression contributes to age-induced cardiomyopathy in mice. Circulation 116 (2007) 2139-2147
40. Linz W., Wohlfart P., Baader M., Breitschopf K., Falk E., Schafer H.L., et al. The peroxisome proliferator-activated receptor-alpha (PPAR-alpha) agonist, AVE8134, attenuates the progression of heart failure and increases survival in rats. Acta Pharmacol Sin (2009)
41. Su H.F., Samsamshariat A., Fu J., Shan Y.X., Chen Y.H., Piomelli D., et al. Oleylethanolamide activates Ras-Erk pathway and improves myocardial function in doxorubicin-induced heart failure. Endocrinology 147 (2006) 827-834
42. Zhou Y., Luo P., Chang H.H., Huang H., Yang T., Dong Z., et al. Colfibrate attenuates blood pressure and sodium retention in DOCA-salt hypertension. Kidney Int 74 (2008) 1040-1048
43. Yang Y., Chen M., Georgeson K.E., and Harmon C.M. Mechanism of oleoylethanolamide on fatty acid uptake in small intestine after food intake and body weight reduction. Am J Physiol Regul Integr Comp Physiol 292 (2007) R235-R241